Your current web browser is outdated. For best viewing experience, please consider upgrading to the latest version.

RSVP

Forum

Examining New York City's "Harm Reduction" Experiment

Dr. Bertha Madras Harvard Medical School
Bryce Pardo RAND Corporation
Kailin See OnPoint NYC
Michael Hendrix Senior Fellow; Director, State and Local Policy, Manhattan Institute
Charles Fain Lehman Senior Fellow, Manhattan Institute
Thu, Jun 23, 2022 New York, N.Y.

Thank you for your RSVP.

ERROR
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed
ERROR
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed
search DONATE
Close Nav

Examining New York City's "Harm Reduction" Experiment

back to top
SEE ALL EVENTS
Forum

Examining New York City's "Harm Reduction" Experiment

Dr. Bertha Madras Harvard Medical School
Bryce Pardo RAND Corporation
Kailin See OnPoint NYC
Michael Hendrix Senior Fellow; Director, State and Local Policy, Manhattan Institute Charles Fain Lehman Senior Fellow, Manhattan Institute New York, N.Y. 06:00pm—07:30pm
Thursday June 23
Thursday June 23 2022
PAST EVENT Thursday June 23 2022

New York City opened the nation’s first officially sanctioned supervised consumption sites (SCSs) last December in response to the city’s growing drug crisis. The SCSs in East Harlem and Washington Heights provide people who use drugs with a place to consume drugs under the supervision of medical professionals, who are armed with overdose-reversing naloxone. The stated goal of supervised consumption sites is to reduce the individual harms associated with drug use.

Harm reduction is rapidly becoming a central theme in drug policy. But there is still much we don’t know about how, or whether, such interventions work. Does a more accepting stance toward drug use reduce overdose deaths? Do SCSs curb or contribute to public disorder? Are harm reduction interventions scalable, and do we know what success looks like? These are difficult but important questions. So far, the New York City Department of Health and Mental Hygiene has been frustratingly opaque about its plans to evaluate the effects of the first American SCSs.

This Klinsky Leadership Series event will explore the debates around New York City’s SCSs and the harm reduction strategies informing their implementation.

TOPICS
Urban PolicyNYCRegulation
Saved!
Close